R A Danguilan
Overview
Explore the profile of R A Danguilan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
35
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pamugas G, Arakama M, Danguilan R, Ledesma D
Transplant Proc
. 2016 May;
48(3):852-4.
PMID: 27234751
Background: Under the Universal Health Care Program of the Department of Health, the Philippine Health Insurance Corporation (PHIC) launched the Case Type Z benefit package for kidney transplantation, providing the...
2.
Suguitan G, Cabanayan-Casasola C, Danguilan R, Jaro J
Transplant Proc
. 2014 May;
46(4):1074-6.
PMID: 24815132
Background: The Human Organ Preservation Effort is a government organ procurement organization that pioneered the Deceased Organ Donation Program in the Philippines. Deceased organ donation comprises only 20% of kidney...
3.
Danguilan R, Lamban A, Luna C, Bacinillo M, Momongan M
Transplant Proc
. 2014 Mar;
46(2):415-7.
PMID: 24655977
Aim: The aim of this study was to establish the efficacy and safety of generic mycophenolate mofetil (Mycept) and determine the bioequivalence with Cellcept. This will provide patients an alternative...
4.
Danguilan R, De Belen-Uriarte R, Jorge S, Lesaca R, Amarillo M, Ampil R, et al.
Transplant Proc
. 2012 May;
44(4):839-42.
PMID: 22564562
Background: The increasing number of patients requiring transplantation has brought about a shortage of donor kidneys. Incentives can potentially improve organ donation. There is a need to know if the...
5.
Santos S, Carlos C, Cabanayan-Casasola C, Danguilan R
Transplant Proc
. 2012 Feb;
44(1):154-60.
PMID: 22310603
Background: Although calcineurin inhibitors (CNIs) has improved short-term graft survival, long-term function remains a challenge. CNIs have been implicated in the development of chronic allograft failure. Low-dose cyclosporine with everolimus...
6.
Pamugas G, Danguilan R, Lamban A, Mangati V, Ona E
Transplant Proc
. 2012 Feb;
44(1):101-8.
PMID: 22310590
Background: In the Philippines, maintenance of immunosuppression may not always be affordable, leading to acute rejection and graft loss. The availability of the generic cyclosporine Arpimune could be economically beneficial,...
7.
Uriarte R, Amarillo M, Ampil R, Manauis M, Danguilan R, Ona E
Transplant Proc
. 2010 Feb;
42(1):121-3.
PMID: 20172294
Background: Despite the national advocacy campaign for kidney transplantation from deceased donors in the Philippines 96% of kidneys transplanted into 721 kidney transplants from 1999 to 2001 came from living...
8.
Matoza J, Danguilan R, Chicano S
Transplant Proc
. 2008 Sep;
40(7):2303-6.
PMID: 18790219
Objective: This study was performed to determine the incidence, treatment, and outcomes of Banff borderline acute rejection (AR) among renal transplant recipients. Patients And Methods: We reviewed the courses of...
9.
Munoz A, Cabanayan-Casasola C, Danguilan R, Padua F, Ona E
Transplant Proc
. 2008 Sep;
40(7):2230-3.
PMID: 18790200
Objective: The purpose of this study was to evaluate the safety and efficacy of induction with Campath-1H with low-dose cyclosporine (CsA) monotherapy using outcome measures of acute rejection episodes (ARE),...
10.
Ona E, Danguilan R, Africa J, Cabanayan-Casasola C, Antonio Z, Gutierrez-Marbella M, et al.
Transplant Proc
. 2008 Sep;
40(7):2226-9.
PMID: 18790199
Alemtuzumab (Campath-1H) is a monoclonal antibody directed against CD52-positive B and T lymphocytes. Initial results of its use as an induction agent in adult renal transplantation have been encouraging. We...